Minerva claims 'positive' PhII data on depression drug while skeptics push stock down - Endpoints News

Submitted by Anonymous (not verified) on Mon, 05/13/2019 - 14:52

Minerva claims 'positive' PhII data on depression drug while skeptics push stock down  Endpoints NewsIt might have come in a bit of an unorthodox shape, but Minerva Neurosciences says it has a Phase II win in its hands. When measured against the bar of a ...